Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Charting the RNA Epigenome

Published: Monday, December 16, 2013
Last Updated: Monday, December 16, 2013
Bookmark and Share
In science, sometimes you need to dive deep to see the big picture.

Scientists at the Broad Institute have demonstrated this time and again, enabling biological discoveries by generating dense maps, such as the survey of thousands of epigenetic marks on DNA across the human genome conducted as part of the ENCODE project.

A team led by Broad researchers has recently created the first high-resolution map of another epigenetic landscape – the RNA epigenome, also known as the “epitranscriptome.” The work appears in the December 5 issue of Cell.

It’s been known since the 1970s that RNA, like DNA, can be tagged with methyl groups, in one kind of epigenetic modification. When DNA or chromatin is methylated, it can alter gene activity by making genes more or less open to being transcribed. The function of RNA methylation, however, has remained a mystery since the discovery of this phenomenon decades ago. A detailed map of epigenetic marks on mRNA across the transcriptome would allow scientists to start navigating the epitranscriptome and begin uncovering its functional role.

One reason RNA methylation is so elusive is that RNA can be tricky to work with. “When working with RNA, we often try to turn it into DNA as soon as possible, because DNA is stable and RNA is not,” said Schraga Schwartz, first author on the new study and a postdoctoral researcher in the laboratories of Broad core faculty members Eric Lander and Aviv Regev, a senior author. “But when studying epigenetic modifications of RNA, once you’ve turned it into DNA, it’s too late. The modifications are no longer going to be there. Whatever you do has to be done at the RNA level.”

Decades ago, scientists pioneered methods of using antibodies to capture modified fragments of the genetic material, but once the fragments were isolated, they had difficulty identifying them. Only with the latest advances in RNA sequencing – and more recently, methods to sequence very small amounts of RNA – could scientists begin to make real headway in the study of the epitranscriptome.

“Until recently, we just knew there was a lot of RNA methylation going on,” said Schwartz. “But nobody knew where.” He explained that better methods to map the modification of messenger RNA across the transcriptome are a first step to uncovering the modifications’ functional roles. “Where is this happening? That’s pretty much an elementary question before starting to address function.”

Before joining the Broad two years ago, Schwartz was part of a research team in Israel that developed a method to study RNA methylation by incorporating RNA sequencing.

At the Broad, Schwartz together with research associate Maxwell Mumbach further optimized the technique in several ways: by reducing the RNA fragment size used in sequencing, which increased the resolution of their map, and reducing the necessary amount of starting material. The team then joined forces with Sudeep Agarwala and Gerald Fink of the Whitehead Institute to map methylations in yeast cells, which experience peaks of RNA modification during meiosis, giving the scientists a dynamic system to study. “In yeast cells, we can really follow methylation as it comes and goes,” said Schwartz. Using yeast cells, the team was also able to shut down the enzyme that adds methyl groups to RNA, allowing them to eliminate many false positive sites.

These advances produced a high-resolution map of more than 1,300 sites of RNA methylation across the yeast transcriptome, down to the single nucleotide. The researchers also characterized the role of three proteins that make up the methylation machinery, shedding light on how these proteins are specifically regulated during meiosis. In addition, they identified a novel protein that binds specifically to methylated RNA. Future studies of these proteins should yield clues about the role of RNA methylations in the cell.

The precise regulation of methylation levels during meiosis suggests an important, still unknown, functional role for RNA methylation. Schwartz, Regev, and their fellow scientists are now pursuing studies to uncover the function of these epitranscriptomic changes, by perturbing those sites in both yeast and mammalian cells. “Our hope is that yeast can serve as a model organism for uncovering function and that a lot of this information will be applicable to humans, given the large extent of conservation that we find,” said Schwartz.

Results of this work may yield insights into disease mechanisms. For example, the top gene associated with obesity, FTO, is an enzyme involved in RNA methylation and, for this reason, obesity researchers are very interested in understanding more about the epitranscriptome.

With this new high-resolution map in hand, scientists can begin exploring the landscape of the RNA epitranscriptome. The work illustrates the importance of mapping in biological study. “You cannot navigate without a map,” explained Schwartz. “One of the most informative things one could do to discover the function of RNA methylation is to perturb specific sites, but that’s only possible once you know where the sites are.”

The field of epitranscriptomics is still relatively new, since techniques that make it feasible only arose in the last couple of years, explains Schwartz. “It’s fascinating for me to follow a field from its infancy and see how knowledge gradually accumulates over time through the joint work of an entire community.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
Thursday, September 29, 2016
High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
Thursday, September 15, 2016
Delivering Beneficial Bacteria
Method that transports microbes through the stomach to the intestine may benefit human health.
Thursday, September 15, 2016
Linking RNA Structure and Function
Biologists have deciphered a lncRNA structure and used the information to investigate its cellular protein interactions.
Friday, September 09, 2016
Hacking Microbes
Startup’s engineered yeast helps clients produce fragrances and flavors more efficiently.
Thursday, September 08, 2016
Guided Needles Hit the Mark
New sensor could help anesthesiologists place needles for epidurals and other medical procedures.
Thursday, September 08, 2016
Changing Ocean Chemistry Due To Human Activity
More anthropogenic carbon in the northeast Pacific means weaker shells for many marine species.
Wednesday, September 07, 2016
Targeting Neglected Diseases
New enzyme-mapping advancement could help drug development for combating diseases in the developing world.
Wednesday, August 17, 2016
Protecting Privacy in Genomic Databases
System helps ensure databases used in medical research will not leak patients’ personal information.
Wednesday, August 10, 2016
Biopharmaceuticals on Demand
Portable production system would use microbes for manufacturing small amounts of vaccines and therapeutics.
Monday, August 01, 2016
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Wednesday, July 27, 2016
New Device can Study Electric Field Cancer Therapy
Microfluidic device allows study of electric field cancer therapy through low-intensity fields, preventing malignant cells spreading.
Friday, July 08, 2016
Programmable RNA Vaccines
Tests in mice show the vaccines work against Ebola, influenza, and a common parasite.
Wednesday, July 06, 2016
Seeing RNA at the Nanoscale
MIT researchers have developed a new way to image proteins and RNA inside neurons of brain tissue.
Wednesday, July 06, 2016
Tough New Hydrogel Hybrid Doesn’t Dry Out
Water-based material could be used to make artificial skin, longer-lasting contact lenses.
Friday, July 01, 2016
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!